Replies to post #92756 on $heff's $tation of $tocks & $olid DD

[$heff]

$PETX..$2.68..close today. The risk/reward looks more solid here than before. On watch to increase from starter to full position in the near-term.

Message in reply to:

$PETX $2.80 Bought another tranche in this name as it moves south with the rest of the market. Should be in a good position to recover into it's catalyst:

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced the Company filed an administrative New Animal Drug Application (NADA) with the Food and Drug Administration's Center for Veterinary Medicine (CVM) for Galliprant® for the control of pain and inflammation in dogs with osteoarthritis. The Animal Drug User Fee Act (ADUFA) date for approval is set for March 25.